Cancer Drug Resistance
Country
United States
Northern America
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Cancer Research
Q1
└
Pharmacology (medical)
Q1
Publisher
SJR 2025
1.775
Q1
SJR Score
H-Index
36
Citations / Doc (2yr)
6.92
Total Docs. (latest)
47
Total Citations (3yr)
1,184
Publication type
Journals
ISSN
2578532X
Coverage
2018-2025
Journal Rank
#1,791
Subject Categories
Cancer Research
Q1
Pharmacology (medical)
Q1
Subject Areas
Aims & Scope
Year
Value
2024
Q1
Abstracting & Indexing
Scopus
Google Scholar
Web of Science
Embase
Detailed Metrics
| Total Docs. (latest) | 47 |
| Total Docs. (3 years) | 179 |
| Total Refs. | 5,506 |
| Total Citations (3 years) | 1,184 |
| Citable Docs. (3 years) | 177 |
| Citations / Doc. (2 years) | 6.92 |
| Ref. / Doc. | 117.15 |
| % Female | 42.5% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Cancer Drug Resistance?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Cancer Drug Resistance has an SJR of 1.775 and is ranked Q1.
What is the SJR and quartile of Cancer Drug Resistance?
Cancer Drug Resistance has an SJR (SCImago Journal Rank) of 1.775 and its best quartile is Q1.
What is the H-index of Cancer Drug Resistance?
The H-index of Cancer Drug Resistance is 36, meaning 36 of its articles have each been cited at least 36 times.
Is Cancer Drug Resistance indexed in Scopus?
Yes. Cancer Drug Resistance is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.